Shot of a scientist using a virtual reality headset while conducting research in a laboratory.
© [M] Munich Re [1] Moyo Studio / Getty Images

AI in Healthcare

Seizing the opportunities for prevention, diagnosis and treatment

Life Science Report 2025

    alt txt

    properties.trackTitle

    properties.trackSubtitle

    Artificial Intelligence is transforming the healthcare landscape at an unprecedented pace. For insurers, healthcare professionals, and patients alike, AI holds the promise of revolutionizing every single aspect of care – from earlier diagnoses to personalized treatment options. Insurers will need to leverage cutting-edge medical expertise and stay ahead of evolving trends to navigate this transformative landscape successfully.

    Munich Re's Life Science Report provides a comprehensive guide to assessing both the promises and pitfalls of emerging medical trends and risks, helping life and health insurers to better navigate this environment of changing mortality and morbidity. The report examines the topics of Artificial Intelligence in Healthcare, Improving Cancer Outcomes, Prevention, Obesity and Climate Change.

    AI in Healthcare – Key Facts

    Better prevention, earlier diagnosis and individualized therapies improve mortality and morbidity rates.
    Vast datasets from electronic health records, imaging and other biomedical sources make risk selection more accurate.
    Critical illness insurance products need continuous updates to account for emerging diagnoses and disease classifications. Potential overdiagnosis and antiselection will have to be monitored closely.
    Claims management becomes more complex due to genetic and molecular diagnoses, requiring cutting-edge medical expertise.

    AI in Healthcare

    Explore our edition on "AI in Healthcare" and find out more about the implications for life and health insurers.

    Explore the Life Science Report

    Subscribe to newsletter for other topics

    Stay tuned for the other topics in our Life Science Report 2025. Over five editions published in the first quarter of 2025, our global medical team will explore key trends and risks that have the potential to reshape the mortality and morbidity landscape: 

    • Artificial Intelligence in Healthcare,
    • Improving Cancer Outcomes,
    • Prevention,
    • Obesity,
    • Climate Change. 

    The report provides life and health insurers an actionable guide to prepare for the underlying business implications. Sign up for email updates on upcoming editions. Please note that we will contact you once to ask for your consent for further communication according to our privacy policy

    Please enter a value. This selection is mandatory.
    Please enter a value.
    Please enter a value.
    Please enter your e-mail address.
    Thank you for your message. Your message has been sent to our Life Science Report team.
    Something went wrong please try again!

    Contact our experts

    Andreas Armuss
    Dr. Andreas Armuss
    Chief Medical Officer
    Munich Re Life & Health
    Asia-Pacific, Middle East & Africa
    Matthew Paul
    Dr. Matthew Paul
    Chief Medical Officer
    Munich Re Life & Health
    Australia & New Zealand
    Hao Liu
    Dr. Hao Liu
    Chief Medical Proposition Officer
    Munich Re Life & Health
    Asia-Pacific
    Jaee Menon
    Dr. Jaee Menon
    Chief Medical Consultant
    Munich Re Life & Health
    South Asia, Southeast Asia, GCC
    Alban Senn
    Dr. Alban Senn
    Chief Medical Officer, Head of Medical Research & Development
    Munich Re Life & Health
    Europe & Latin America
    Javier Gracia San Román
    Dr. Javier Gracia San Román
    Chief Medical Officer
    Munich Re Life & Health
    Southern Europe & Latin America
    Mathias Orban
    Prof. Dr. Mathias Orban
    Senior Medical Consultant
    Munich Re Life & Health
    Europe & Latin America
    Christiane Suchy
    Dr. Christiane Suchy
    Medical Consultant
    Munich Re Life & Health
    Europe & Latin America
    Gina Guzman
    Dr. Gina Guzman
    Vice President & Chief Medical Director
    Munich Re Life US
    Timothy Meagher
    Dr. Tim Meagher
    Vice President & Medical Director
    Munich Re, Canada (Life)
    Bradley Heltemes
    Dr. Bradley Heltemes
    Vice President & Medical Director of R&D
    Munich Re Life US